Resurgent Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270K | Buy |
607
+6
| +1% | +$2.67K | 0.15% | 153 |
|
|
2025
Q1 | $291K | Buy |
601
+15
| +3% | +$7.27K | 0.18% | 141 |
|
|
2024
Q4 | $236K | Sell |
586
-294
| -33% | -$118K | 0.14% | 157 |
|
|
2024
Q3 | $409K | Sell |
880
-19
| -2% | -$8.84K | 0.24% | 124 |
|
|
2024
Q2 | $421K | Sell |
899
-100
| -10% | -$46.9K | 0.26% | 116 |
|
|
2024
Q1 | $418K | Buy |
999
+189
| +23% | +$79K | 0.22% | 121 |
|
|
2023
Q4 | $330K | Buy |
810
+574
| +243% | +$234K | 0.2% | 124 |
|
|
2023
Q3 | $82.1K | Buy |
236
+17
| +8% | +$5.91K | 0.06% | 252 |
|
|
2023
Q2 | $77.1K | Sell |
219
-7
| -3% | -$2.46K | 0.05% | 268 |
|
|
2023
Q1 | $71.2K | Sell |
226
-473
| -68% | -$149K | 0.05% | 278 |
|
|
2022
Q4 | $202K | Sell |
699
-634
| -48% | -$183K | 0.11% | 199 |
|
|
2022
Q3 | $386K | Buy |
1,333
+72
| +6% | +$20.8K | 0.26% | 104 |
|
|
2022
Q2 | $355K | Sell |
1,261
-76
| -6% | -$21.4K | 0.23% | 114 |
|
|
2022
Q1 | $349K | Buy |
+1,337
| New | +$349K | 0.22% | 114 |
|